Fasting and Caloric Restriction Activate an ADIOL-NHR-91-Kynurenine Pathway Signaling Axis to Promote Healthspan.
Abstract
The steroid hormone 5-androstene-3β,17β-diol (ADIOL) was discovered nearly a century ago in humans, yet its physiological functions have remained poorly understood. Using C. elegans, we identify ADIOL as essential for several pro-healthspan effects of fasting and caloric restriction (CR). These dietary restriction regimens activate an ADIOL-NHR-91-kynurenic acid signaling axis, partly through transcriptional programs associated with ADIOL biosynthesis. Within this axis, ADIOL acts through NHR-91, a C. elegans homolog of estrogen receptor β, to reduce levels of kynurenic acid, a neuromodulatory metabolite, thereby enhancing healthspan. Critically, ADIOL does not extend lifespan, indicating its healthspan benefits are independent of longevity, and even late-life supplementation is effective. Collectively, this work establishes ADIOL as a physiological link between metabolic cues and neural function, promoting health during aging via the kynurenine pathway. Given that in mammals ADIOL similarly is a ligand for estrogen receptor β and the kynurenine pathway influences neuroprotection mechanisms, ADIOL may represent an evolutionarily conserved signal by which dietary interventions enhance healthy aging.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that ADIOL activates a signaling axis that enhances healthspan independent of lifespan extension. This research is relevant as it explores the physiological mechanisms linking dietary interventions to health during aging, addressing potential pathways that could mitigate age-related decline.
Author of this paper? Send a correction.